Your session is about to expire
← Back to Search
Clairity for Mental Health Issue (FECU Trial)
N/A
Waitlist Available
Research Sponsored by Clarigent Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 month
Awards & highlights
FECU Trial Summary
This trial is testing a new tool to help university students with mental health problems.
Eligible Conditions
- Mental Health Issue
- Suicide
- Depression
- Anxiety
FECU Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Clairity Dashboard
Clinical Utility Treatment Outcomes
Identify Mental States with Area Under the AUC metric
+1 moreFECU Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TreatmentExperimental Treatment1 Intervention
Participants will complete a Clairity session between their regular therapy visits. The Clairity interview is between 4-11 minutes where a clinical research coordinator will ask participants questions about hope, secrets, anger, fear, and emotional pain.
Group II: ControlActive Control1 Intervention
Participants will submit demographics and medical records and will only complete standard of care.
Find a Location
Who is running the clinical trial?
Xavier UniversityUNKNOWN
Clarigent HealthLead Sponsor
2 Previous Clinical Trials
2,022 Total Patients Enrolled
Xavier University of Louisiana.OTHER
6 Previous Clinical Trials
2,728 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You can speak and understand English well.You have an intellectual or neurocognitive disability that the study staff thinks may prevent you from participating.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger